$8.50
-0.70 (-7.61%)
Gentium S.p.A. (ADR) (NASDAQ:GENT)
CAPS Rating:
A biopharmaceutical company engaged in the research, development and manufacture of drugs to treat and prevent a variety of vascular diseases and conditions related to cancer and cancer treatments.
RSS Headlines
Fool UK